Truist Securities Maintains Buy on Ovintiv, Raises Price Target to $77
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
Truist Securities analyst Gabe Daoud maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $73 to $77.
Truist Securities analyst Gabe Daoud maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $73 to $77.